IL271852B2 - Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof - Google Patents

Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof

Info

Publication number
IL271852B2
IL271852B2 IL271852A IL27185220A IL271852B2 IL 271852 B2 IL271852 B2 IL 271852B2 IL 271852 A IL271852 A IL 271852A IL 27185220 A IL27185220 A IL 27185220A IL 271852 B2 IL271852 B2 IL 271852B2
Authority
IL
Israel
Prior art keywords
quercetin
process according
phospholipids
solid dispersion
solution
Prior art date
Application number
IL271852A
Other languages
English (en)
Hebrew (he)
Other versions
IL271852A (en
IL271852B1 (en
Original Assignee
Indena Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Indena Spa filed Critical Indena Spa
Publication of IL271852A publication Critical patent/IL271852A/en
Publication of IL271852B1 publication Critical patent/IL271852B1/en
Publication of IL271852B2 publication Critical patent/IL271852B2/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/105—Plant extracts, their artificial duplicates or their derivatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/0216—Solid or semisolid forms
    • A61K8/022—Powders; Compacted Powders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
    • A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
    • A61K8/9783—Angiosperms [Magnoliophyta]
    • A61K8/9789—Magnoliopsida [dicotyledons]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/145—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/141—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers
    • A61K9/146—Intimate drug-carrier mixtures characterised by the carrier, e.g. ordered mixtures, adsorbates, solid solutions, eutectica, co-dried, co-solubilised, co-kneaded, co-milled, co-ground products, co-precipitates, co-evaporates, co-extrudates, co-melts; Drug nanoparticles with adsorbed surface modifiers with organic macromolecular compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1617—Organic compounds, e.g. phospholipids, fats
    • A61K9/1623—Sugars or sugar alcohols, e.g. lactose; Derivatives thereof; Homeopathic globules
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
    • A61K9/1605—Excipients; Inactive ingredients
    • A61K9/1629—Organic macromolecular compounds
    • A61K9/1652—Polysaccharides, e.g. alginate, cellulose derivatives; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2009—Inorganic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2022—Organic macromolecular compounds
    • A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2200/00—Function of food ingredients
    • A23V2200/30—Foods, ingredients or supplements having a functional effect on health
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2121/00—Preparations for use in therapy
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
    • A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Mycology (AREA)
  • Inorganic Chemistry (AREA)
  • Botany (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Nutrition Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Cosmetics (AREA)
IL271852A 2017-07-17 2018-07-16 Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof IL271852B2 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP17181634 2017-07-17
PCT/EP2018/069284 WO2019016146A1 (en) 2017-07-17 2018-07-16 SOLID POWDER DISPERSIONS COMPRISING QUERCETIN, PROCESS FOR PREPARING SAME AND FORMULAS THEREOF

Publications (3)

Publication Number Publication Date
IL271852A IL271852A (en) 2020-02-27
IL271852B1 IL271852B1 (en) 2024-03-01
IL271852B2 true IL271852B2 (en) 2024-07-01

Family

ID=59381081

Family Applications (1)

Application Number Title Priority Date Filing Date
IL271852A IL271852B2 (en) 2017-07-17 2018-07-16 Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof

Country Status (17)

Country Link
US (1) US11331298B2 (cg-RX-API-DMAC7.html)
EP (1) EP3654938B1 (cg-RX-API-DMAC7.html)
JP (1) JP7284743B2 (cg-RX-API-DMAC7.html)
KR (1) KR20200030076A (cg-RX-API-DMAC7.html)
CN (1) CN110944624A (cg-RX-API-DMAC7.html)
AU (1) AU2018304534B2 (cg-RX-API-DMAC7.html)
CA (1) CA3069055A1 (cg-RX-API-DMAC7.html)
DK (1) DK3654938T3 (cg-RX-API-DMAC7.html)
ES (1) ES2929981T3 (cg-RX-API-DMAC7.html)
FI (1) FI3654938T3 (cg-RX-API-DMAC7.html)
HU (1) HUE060387T2 (cg-RX-API-DMAC7.html)
IL (1) IL271852B2 (cg-RX-API-DMAC7.html)
PL (1) PL3654938T3 (cg-RX-API-DMAC7.html)
PT (1) PT3654938T (cg-RX-API-DMAC7.html)
SG (1) SG11202000141WA (cg-RX-API-DMAC7.html)
SI (1) SI3654938T1 (cg-RX-API-DMAC7.html)
WO (1) WO2019016146A1 (cg-RX-API-DMAC7.html)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20210393579A1 (en) * 2020-06-23 2021-12-23 Zestt Wellness Limited Anthocyanin and Quercetin Based Formulations for Improved Respiratory Health
JP7123434B1 (ja) 2021-03-17 2022-08-23 株式会社アイビー化粧品 破骨細胞分化抑制剤
CN113712988A (zh) * 2021-08-17 2021-11-30 塔里木大学 一种槲皮素-替米考星聚合物纳米微粒、其制备方法及应用
IT202200002108A1 (it) 2022-02-07 2023-08-07 Indena Spa Composizioni a base di quercetina per il trattamento e la prevenzione di affezioni oculari
KR102653457B1 (ko) * 2023-12-20 2024-04-02 서울대학교산학협력단 장 점막 부착성이 향상된 쿼세틴 함유 분말 제제의 제조방법 및 이에 따라 제조된 쿼세틴 함유 분말 제제
KR20260108310A (ko) * 2024-12-30 2026-07-08 대상웰라이프 주식회사 구강 건강 개선용 조성물의 제조 방법 및 이로부터 제조된 구강 건강 개선용 조성물

Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1813677A (zh) * 2005-12-06 2006-08-09 四川大学 槲皮素长效脂质体粉针剂及其制备方法
CN101904821A (zh) * 2009-06-02 2010-12-08 姜玲敏 槲皮素纳米冻干粉及其制备方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN100367953C (zh) * 2006-03-06 2008-02-13 山东大学 槲皮素固体脂质纳米粒制剂及其制备方法
CN102058536A (zh) 2011-01-14 2011-05-18 四川大学 槲皮素羟丙基β-环糊精包和物脂质体及其制备方法和用途

Patent Citations (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1813677A (zh) * 2005-12-06 2006-08-09 四川大学 槲皮素长效脂质体粉针剂及其制备方法
CN101904821A (zh) * 2009-06-02 2010-12-08 姜玲敏 槲皮素纳米冻干粉及其制备方法

Also Published As

Publication number Publication date
EP3654938B1 (en) 2022-08-31
SG11202000141WA (en) 2020-02-27
IL271852A (en) 2020-02-27
HUE060387T2 (hu) 2023-02-28
IL271852B1 (en) 2024-03-01
AU2018304534B2 (en) 2024-07-11
CN110944624A (zh) 2020-03-31
JP7284743B2 (ja) 2023-05-31
JP2020527549A (ja) 2020-09-10
RU2020106924A3 (cg-RX-API-DMAC7.html) 2021-11-17
AU2018304534A1 (en) 2020-02-06
US11331298B2 (en) 2022-05-17
RU2020106924A (ru) 2021-08-17
SI3654938T1 (sl) 2022-11-30
KR20200030076A (ko) 2020-03-19
PT3654938T (pt) 2022-11-03
FI3654938T3 (fi) 2022-12-15
BR112020000841A2 (pt) 2020-07-21
CA3069055A1 (en) 2019-01-24
WO2019016146A1 (en) 2019-01-24
US20200206186A1 (en) 2020-07-02
PL3654938T3 (pl) 2022-12-27
EP3654938A1 (en) 2020-05-27
ES2929981T3 (es) 2022-12-05
DK3654938T3 (da) 2022-10-03

Similar Documents

Publication Publication Date Title
AU2018304534B2 (en) Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof
EP2172223B1 (en) Composition containing physiologically active substance
EP2172196B1 (en) Composition containing coenzyme q10
EP2098222A1 (en) Physiologically active substance-containing granular composition and method of producing the same
JPS63277691A (ja) サポニンとりん脂質との複合体及びそれらを含有する薬学的及び化粧用の組成物
AU2005290583A1 (en) Fine particles-containing composition and manufacturing method therefor
CA2988478C (en) Solid dispersions of coenzyme q10
Bazylińska et al. Engineering of phosphatidylcholine-based solid lipid nanocarriers for flavonoids delivery
KR20130139869A (ko) 지방 저감제
RU2772020C2 (ru) Порошкообразные твердые дисперсии, включающие кверцетин, способ их получения и их композиции
JP2016053000A (ja) 水分散性の良いシリマリン含有組成物
HK40023880A (en) Powder solid dispersions comprising quercetin, process for their preparation and formulations thereof
Pal et al. Prospects of nanophytosomes in nanomedicine
EP3895695A1 (en) Supercritical carbon dioxide-based methodology to formulate bioactive preparations
JP5114397B2 (ja) ヒアルロン酸リン脂質複合体及びその調製法
KR20230136513A (ko) 비타민 c의 안정한 서방성 제형 및 이의 제조 방법
BR112020000841B1 (pt) Dispersões sólidas de pó compreendendo quercetina, processo para seu preparo e suas formulações
ES2787229T3 (es) Composición que contiene coenzima Q10
Sultana et al. INTERNATIONAL JOURNAL OF UNIVERSAL PHARMACY AND BIO SCIENCES
WO2021153485A1 (ja) クルクミン類含有組成物及びその製造方法
JP7405823B2 (ja) アメリカンクランベリー抽出物およびリン脂質を含む組成物
SK7424Y1 (sk) Komplexy kyseliny linolovej, spôsob ich prípravy a ich použitie